| Expression pattern: |
UP |
| Associated gene: |
MLLT1 |
| Associated microRNA: |
miR-150-5p |
| Biological function: |
CircVRK1 knockdown alleviates OGD-induced HBMEC injury by promoting migration and angiogenesis, repressing cell death, and reducing inflammatory response and oxidative stress. |
| Molecular mechanism: |
CircVRK1 acts as a ceRNA by sponging miR-150-5p, thereby positively regulating MLLT1 expression in OGD-induced HBMEC injury. |
| Biological pathway or process: |
ceRNA regulation (promotes); migration (inhibits); angiogenesis (inhibits); apoptosis (promotes); inflammation (promotes); other pathway/process (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Bioinformatics Analysis; Transfection; Transwell Assay; Wound Healing Assay; Tube Formation Assay; Annexin V/PI Flow Cytometry; Western Blot; ELISA; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); RNA Pull-Down |
| Clinical significance: |
CircVRK1 might provide a promising curative target for IS patients. |
| Description: |
CircVRK1 is upregulated in OGD-treated HBMECs, an in vitro model of ischemic stroke. Its knockdown protects HBMECs from OGD-induced injury by reducing cell death, inflammation and oxidative stress while improving migration and angiogenesis, mediated through the miR-150-5p/MLLT1 ceRNA axis. |
| Confidence score: |
0.7624 |